Veracyte (VCYT) Total Liabilities (2012 - 2026)

Veracyte has disclosed Total Liabilities across 15 years of filings, most recently posting $92.0 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $92.0 million, down 23.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $92.0 million (down 23.64% YoY), and the FY2025 annual result was $96.4 million, down 22.27% from the prior year.
• Total Liabilities came in at $92.0 million for Q1 2026 at Veracyte, down from $96.4 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $124.1 million in Q4 2024 to a low of $70.8 million in Q4 2023.
• The 5-year median for Total Liabilities is $88.4 million (2022), against an average of $92.5 million.
• Across the five-year window, Total Liabilities surged 75.23% in 2024 and fell 23.64% in 2026, its largest moves.
• Veracyte's Total Liabilities stood at $81.2 million in 2022, then fell by 12.83% to $70.8 million in 2023, then surged by 75.23% to $124.1 million in 2024, then fell by 22.27% to $96.4 million in 2025, then slipped by 4.61% to $92.0 million in 2026.
• The last three Total Liabilities figures came in at $92.0 million (Q1 2026), $96.4 million (Q4 2025), and $110.1 million (Q3 2025), per Business Quant data.